Literature DB >> 16565508

A novel aspartic proteinase-like gene expressed in stratified epithelia and squamous cell carcinoma of the skin.

Verena Rhiemeier1, Ute Breitenbach, Karl Hartmut Richter, Christoffer Gebhardt, Ingeborg Vogt, Bettina Hartenstein, Gerhard Fürstenberger, Cornelia Mauch, Jochen Hess, Peter Angel.   

Abstract

Homeostasis of stratified epithelia, such as the epidermis of the skin, is a sophisticated process that represents a tightly controlled balance between proliferation and differentiation. Alterations of this balance are associated with common human diseases including cancer. Here, we report the cloning of a novel cDNA sequence, from mouse back skin, that is induced by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) and codes for a hitherto unknown aspartic proteinase-like protein (Taps). Taps represents a potential AP-1 target gene because TPA-induced expression in epidermal keratinocytes critically depends on c-Fos, and co-treatment with dexamethasone, a potent inhibitor of AP-1-mediated gene regulation, resulted in impaired activation of Taps expression. Taps mRNA and protein are restricted to stratified epithelia in mouse embryos and adult tissues, implicating a crucial role for this aspartic proteinase-like gene in differentiation and homeostasis of multilayered epithelia. During chemically induced carcinogenesis, transient elevation of Taps mRNA and protein levels was detected in benign skin tumors. However, its expression is negatively associated with dedifferentiation and malignant progression in squamous cell carcinomas of the skin. Similar expression was observed in squamous skin tumors of patients, suggesting that detection of Taps levels represents a novel strategy to discriminate the progression state of squamous skin cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565508      PMCID: PMC1606566          DOI: 10.2353/ajpath.2006.050871

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

Review 1.  Getting under the skin of epidermal morphogenesis.

Authors:  Elaine Fuchs; Srikala Raghavan
Journal:  Nat Rev Genet       Date:  2002-03       Impact factor: 53.242

Review 2.  Cross-talk between glucocorticoid receptor and AP-1.

Authors:  P Herrlich
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

Review 3.  Making sense of the epithelial barrier: what molecular biology and genetics tell us about the functions of oral mucosal and epidermal tissues.

Authors:  Richard B Presland; Richard J Jurevic
Journal:  J Dent Educ       Date:  2002-04       Impact factor: 2.264

Review 4.  AP-1: a double-edged sword in tumorigenesis.

Authors:  Robert Eferl; Erwin F Wagner
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

5.  Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells.

Authors:  Joerg Schlingemann; Jochen Hess; Gunnar Wrobel; Ute Breitenbach; Christoffer Gebhardt; Peter Steinlein; Heidi Kramer; Gerhard Fürstenberger; Meinhard Hahn; Peter Angel; Peter Lichter
Journal:  Int J Cancer       Date:  2003-05-10       Impact factor: 7.396

6.  c-fos is required for malignant progression of skin tumors.

Authors:  E Saez; S E Rutberg; E Mueller; H Oppenheim; J Smoluk; S H Yuspa; B M Spiegelman
Journal:  Cell       Date:  1995-09-08       Impact factor: 41.582

7.  Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun.

Authors:  Matthew R Young; Linda Farrell; Paul Lambert; Parirokh Awasthi; Nancy H Colburn
Journal:  Mol Carcinog       Date:  2002-06       Impact factor: 4.784

8.  Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis.

Authors:  Christoffer Gebhardt; Ute Breitenbach; Jan Peter Tuckermann; Bernd Thilo Dittrich; Karl Hartmut Richter; Peter Angel
Journal:  Oncogene       Date:  2002-06-20       Impact factor: 9.867

Review 9.  Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4.

Authors:  Matthew R Young; Hsin-Sheng Yang; Nancy H Colburn
Journal:  Trends Mol Med       Date:  2003-01       Impact factor: 11.951

10.  c-Jun regulates eyelid closure and skin tumor development through EGFR signaling.

Authors:  Rainer Zenz; Harald Scheuch; Paul Martin; Carsten Frank; Robert Eferl; Lukas Kenner; Maria Sibilia; Erwin F Wagner
Journal:  Dev Cell       Date:  2003-06       Impact factor: 12.270

View more
  5 in total

1.  ICAM1+ neutrophils promote chronic inflammation via ASPRV1 in B cell-dependent autoimmune encephalomyelitis.

Authors:  Ryder F Whittaker Hawkins; Alexandre Patenaude; Aline Dumas; Rajiv Jain; Yodit Tesfagiorgis; Steven Kerfoot; Takeshi Matsui; Matthias Gunzer; Patrice E Poubelle; Catherine Larochelle; Martin Pelletier; Luc Vallières
Journal:  JCI Insight       Date:  2017-12-07

2.  Mutations in ASPRV1 Cause Dominantly Inherited Ichthyosis.

Authors:  Lynn M Boyden; Jing Zhou; Ronghua Hu; Theodore Zaki; Erin Loring; Jared Scott; Heiko Traupe; Amy S Paller; Richard P Lifton; Keith A Choate
Journal:  Am J Hum Genet       Date:  2020-06-08       Impact factor: 11.025

3.  SASPase regulates stratum corneum hydration through profilaggrin-to-filaggrin processing.

Authors:  Takeshi Matsui; Kenichi Miyamoto; Akiharu Kubo; Hiroshi Kawasaki; Tamotsu Ebihara; Kazuya Hata; Shinya Tanahashi; Shizuko Ichinose; Issei Imoto; Johji Inazawa; Jun Kudoh; Masayuki Amagai
Journal:  EMBO Mol Med       Date:  2011-05-03       Impact factor: 12.137

4.  A de novo variant in the ASPRV1 gene in a dog with ichthyosis.

Authors:  Anina Bauer; Dominik P Waluk; Arnaud Galichet; Katrin Timm; Vidhya Jagannathan; Beyza S Sayar; Dominique J Wiener; Elisabeth Dietschi; Eliane J Müller; Petra Roosje; Monika M Welle; Tosso Leeb
Journal:  PLoS Genet       Date:  2017-03-01       Impact factor: 5.917

5.  Filaggrin and filaggrin 2 processing are linked together through skin aspartic acid protease activation.

Authors:  Mark Donovan; Mélanie Salamito; Agnès Thomas-Collignon; Lucie Simonetti; Stephanie Desbouis; Jean-Christophe Rain; Etienne Formstecher; Dominique Bernard
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.